These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8104930)

  • 1. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.
    Medda P; Perugi G; Zanello S; Ciuffa M; Rizzato S; Cassano GB
    J ECT; 2010 Jun; 26(2):82-6. PubMed ID: 19710623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.
    Anton RF; Burch EA
    Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
    Flint AJ; Rifat SL
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use and tolerability of fluoxetine in geropsychiatric inpatients.
    Orengo CA; Kunik ME; Molinari V; Workman RH
    J Clin Psychiatry; 1996 Jan; 57(1):12-6. PubMed ID: 8543541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How long should patients with psychotic depression stay on the antipsychotic medication?
    Rothschild AJ; Duval SE
    J Clin Psychiatry; 2003 Apr; 64(4):390-6. PubMed ID: 12716238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
    Fabre LF; Scharf MB; Itil TM
    J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Wagner G
    J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.